Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,446 | -5,144 | -6,700 | -6,162 | -4,711 |
| Depreciation Amortization | 214 | 167 | 109 | 97 | 15 |
| Accounts receivable | -890 | 38 | -466 | -184 | 444 |
| Other Working Capital | -835 | -518 | 222 | 17 | 401 |
| Other Operating Activity | 1,316 | 408 | 1,123 | 520 | -33 |
| Operating Cash Flow | $-3,641 | $-5,049 | $-5,712 | $-5,712 | $-3,884 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 825 | 2,214 | 2,181 | 9,249 |
| PPE Investments | -273 | -410 | -337 | -543 | -479 |
| Other Investing Activity | -14 | -14 | -18 | -124 | -13 |
| Investing Cash Flow | $-287 | $401 | $1,859 | $1,514 | $8,757 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,005 | 7,385 | 532 | 2 | 50 |
| Dividend Paid | -11 | -11 | -11 | -11 | -11 |
| Financing Cash Flow | $994 | $7,374 | $521 | $-9 | $39 |
| Beginning Cash Position | 5,507 | 2,781 | 6,113 | 10,320 | 5,227 |
| End Cash Position | 2,573 | 5,507 | 2,781 | 6,113 | 10,139 |
| Net Cash Flow | $-2,934 | $2,726 | $-3,332 | $-4,207 | $4,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,641 | -5,049 | -5,712 | -5,712 | -3,884 |
| Capital Expenditure | -273 | -444 | -337 | -549 | -479 |
| Free Cash Flow | -3,914 | -5,493 | -6,049 | -6,261 | -4,363 |